Avalon globocare announces patent issuance for novel car-t and car-nk cell technology in hong kong

Freehold, n.j., july 14, 2025 (globe newswire) -- avalon globocare corp. (“avalon” or the “company”) (nasdaq: albt), a developer of precision diagnostic consumer products, today announced the issuance of a new standard patent by the hong kong intellectual property department (hkipd) for its proprietary car-t and car-natural killer (nk) cell technology.

ALBT Ratings Summary

ALBT Quant Ranking